Advertisement
Screener

Privia Health Group, Inc. (PRVA) Overview

Privia Health Group, Inc. (PRVA) Overview

  • 1 Apr 2026: Period ending 30 Jun 2026; Estimate (m); Actual 0.07; Beat / miss (m).
  • 1 Jan 2026: Period ending 31 Mar 2026; Estimate (m); Actual 0.02; Beat / miss (m).
  • 1 Jul 2025: Period ending 30 Sept 2025; Estimate (m); Actual 0.05; Beat / miss (m).
  • 1 Apr 2025: Period ending 30 Jun 2025; Estimate (m); Actual 0.02; Beat / miss (m).

Stock Price Chart

View more →

Blue: Split-adjusted close · Orange: Cumulative dividend-reinvested close

$18.15$20.01$22.05$24.30$26.77$29.512025-11-062026-11-06$15.29$18.98$23.57$29.26$36.34$45.122021-11-082026-11-06$15.29$19.50$24.89$31.76$40.53$51.712021-04-282026-11-06$15.29$19.50$24.89$31.76$40.53$51.712021-04-282026-11-06$15.29$19.50$24.89$31.76$40.53$51.712021-04-282026-11-06

Logarithmic scale. Both lines share the same starting value for the selected range.

Last close
$24.42
Previous close
$19.62
Change
$4.80
Change (%)
24.46%
Close date
2026-11-06
Previous close date
2026-09-29
Open
(m)
Day high
(m)
Day low
(m)
Last session volume
(m)
Last session value
(m)
Currency
USD
Price basis
split-adjusted
Volume basis
(m)

Performance

View more →

Cumulative total returns · 2026-09-29

YTD

PRVA
-17.21%
S&P 500
(m)

1 year

PRVA
-19.61%
S&P 500
(m)

3 years

PRVA
-14.65%
S&P 500
(m)

5 years

PRVA
-18.24%
S&P 500
(m)

Earnings trends

View more →

Earnings per share

USD / share · As filed

30 Jun 2026 ○ Estimate (m) ● Actual 0.07

-0.060.020.100.170.2531 Mar 2025: estimate (m); actual 0.0331 Mar 2025(m)30 Jun 2025: estimate (m); actual 0.0230 Jun 2025(m)30 Sept 2025: estimate (m); actual 0.0530 Sept 2025(m)31 Mar 2026: estimate (m); actual 0.0231 Mar 2026(m)30 Jun 2026: estimate (m); actual 0.0730 Jun 2026(m)
Comparison details
Period startPeriod endingEstimateActualBeat / missReport date
1 Apr 202630 Jun 2026(m)0.07(m)(m)
1 Jan 202631 Mar 2026(m)0.02(m)(m)
1 Jul 202530 Sept 2025(m)0.05(m)(m)
1 Apr 202530 Jun 2025(m)0.02(m)(m)
1 Jan 202531 Mar 2025(m)0.03(m)(m)

31 Dec 2025 ○ Estimate (m) ● Actual 0.18

-1.91-1.34-0.77-0.200.3731 Dec 2021: estimate (m); actual -1.8331 Dec 2021(m)31 Dec 2022: estimate (m); actual -0.0831 Dec 2022(m)31 Dec 2023: estimate (m); actual 0.1931 Dec 2023(m)31 Dec 2024: estimate (m); actual 0.1131 Dec 2024(m)31 Dec 2025: estimate (m); actual 0.1831 Dec 2025(m)
Comparison details
Period startPeriod endingEstimateActualBeat / missReport date
1 Jan 202531 Dec 2025(m)0.18(m)(m)
1 Jan 202431 Dec 2024(m)0.11(m)(m)
1 Jan 202331 Dec 2023(m)0.19(m)(m)
1 Jan 202231 Dec 2022(m)-0.08(m)(m)
1 Jan 202131 Dec 2021(m)-1.83(m)(m)

Revenue vs. Earnings

USD

No complete retained periods.

No complete retained periods.

Analyst insights

View more →
RatingsBuyHoldSellOther ratingsLast CloseAverage TargetUpsideHigh TargetLow Target
(m)(m)(m)(m)(m)$24.42(m)(m)(m)(m)
Past 12 Months12 Month ForecastLast Close$24.42High(m)Average(m)Low(m)2025-11-062026-11-06

Recent news

View more →

(m)

YouTube videos mentioning PRVA

View more →

(m)

Statistics

View more →

Retained observations as of 2026-11-11; financial period ending (m).

Forward P/E
(m)
PEG ratio · 5-year expected
(m)
Shares held by insiders
(m)
Insider transactions · change (%)
(m)
Shares held by institutions
(m)
Institutional transactions · change (%)
(m)
Diluted EPS · 12 month
(m)
EPS estimate · next quarter
(m)
EPS estimate · next year
(m)
EPS growth · current annual estimate
(m)
EPS growth · next annual estimate
(m)
EPS growth · next 5 years expected
(m)
EPS growth · past 3 years annualized
(m)
EPS growth · past 5 years annualized
(m)
EPS change · 12 months vs prior year
(m)
EPS change · latest quarter vs previous quarter
(m)
Latest earnings report date
(m)
EPS surprise · latest reported quarter
(m)
Net income · 12 month
(m)
Profit margin
(m)
Return on assets · 12 month
(m)
Stock compensation expense · all employees · 12 months
(m)
Named executive and board stock awards · latest fiscal year
(m)
Index membership
(m)
Employees
(m)
IPO date
(m)
Options available
(m)
Shortable
(m)
Analyst recommendation
(m)
Analyst target price
(m)
Price volatility · week
(m)
Price volatility · month
(m)
Average true range · 14 sessions
(m)
Relative strength index · 14 sessions
(m)
Relative volume
(m)
Average daily volume
1.31M
Latest session volume
(m)
Last session value
(m)
30 days ago session value
(m)
1 year ago session value
(m)
Number of trades
(m)
Total return · week
0.87%*
Total return · month
-5.49%*
Total return · quarter
-23.17%*
Total return · half year
-1.95%*
Total return · year to date
-17.21%*
Total return · 1 year
-19.61%*
Total return · 3 years
-14.65%*
Total return · 5 years
-18.24%*
Market cap
(m)
Book value per share · latest quarter
(m)
Price / cash · latest quarter
(m)
Enterprise value
(m)
Enterprise value / revenue
(m)
Enterprise value / EBITDA
(m)
Dividend · 12 months per share
(m)
Dividend ex-date
(m)
Next dividend ex-date
(m)
Next dividend amount per share
(m)
Dividend growth · 3 years annualized
(m)
Dividend growth · 5 years annualized
(m)
Revenue · 12 month
(m)
Revenue growth · past 3 years annualized
(m)
Revenue growth · past 5 years annualized
(m)
Revenue change · 12 months vs prior year
(m)
Revenue change · latest quarter vs previous quarter
(m)
Revenue surprise · latest reported quarter
(m)
Levered free cash flow · 12 month
(m)
Debt / equity · latest quarter
(m)
Long-term debt / equity · latest quarter
(m)
Return on equity · 12 month
(m)
Return on invested capital · 12 months
(m)
Previous close
(m)
Latest closing price
(m)
Latest session change (%)
(m)
52-week high
(m)
52-week low
(m)
Price vs 20-session moving average
(m)
Price vs 50-session moving average
(m)
Price vs 200-session moving average
(m)
Float shares
(m)
Short float (%)
(m)
Short ratio (days to cover)
(m)
Short interest (shares)
(m)

Five-year projected P/E and P/S repeat the preceding five-year EPS and revenue CAGR, holding current price and market cap constant. Hover a calculated row for its formula. Net assets = assets − debt − payables − deferred revenue − obligations due within 1 year − obligations due after 1 year.

Holders breakdown

View more →
BreakdownOwnership
(m)Shares held by all insiders
(m)Shares held by institutions
(m)Float held by institutions
(m)Institutions holding shares

Other holders

(m)

View more →

Insider holders

(m)

View more →

Top institutional holders

(m)

View more →

Top mutual fund holders

(m)

View more →

Privia Health Group, Inc. Overview

View more →

(m)

(m)

SEC CIK
1759655
Industry (SIC)
8000 Services-Health Services
Country of operation
United States
Business address
950 N. GLEBE RD., SUITE 700, ARLINGTON, Virginia, 22203, United States
Fiscal year end
1231
Phone
571-366-8850

Similar stocks

Stock NameCountryMarket CapPE Ratio
GeneDx Holdings Corp. (WGS)United States$2.638B-19.23
Pennant Group, Inc. (PNTG)United States$1.386B39.84
U S PHYSICAL THERAPY INC /NV (USPH)United States$1.251B32.48
Omada Health, Inc. (OMDA)United States$1.207B309.08
InnovAge Holding Corp. (INNV)United States$1.206B-635.60
Strata Critical Medical, Inc. (SRTA)United States$0.467B11.33
LifeStance Health Group, Inc. (LFST)United States$4.510B80.86
DocGo Inc. (DCGO)United States$0.034B-0.25
VSEE HEALTH, INC. (VSEE)United States$0.003B
Agape ATP Corp (ATPC)$0.002B